198 related articles for article (PubMed ID: 33752243)
1. Free fatty acid receptor 4 responds to endogenous fatty acids to protect the heart from pressure overload.
Murphy KA; Harsch BA; Healy CL; Joshi SS; Huang S; Walker RE; Wagner BM; Ernste KM; Huang W; Block RC; Wright CD; Tintle N; Jensen BC; Wells QS; Shearer GC; O'Connell TD
Cardiovasc Res; 2022 Mar; 118(4):1061-1073. PubMed ID: 33752243
[TBL] [Abstract][Full Text] [Related]
2. FFAR4 regulates cardiac oxylipin balance to promote inflammation resolution in HFpEF secondary to metabolic syndrome.
Zhang N; Harsch B; Zhang MJ; Gyberg DJ; Stevens JA; Wagner BM; Mendelson J; Patterson MT; Orchard DA; Healy CL; Williams JW; Townsend D; Shearer GC; Murphy KA; O'Connell TD
J Lipid Res; 2023 Jun; 64(6):100374. PubMed ID: 37075982
[TBL] [Abstract][Full Text] [Related]
3. Free fatty acid receptor 4 in cardiac myocytes ameliorates ischemic cardiomyopathy.
Zhang MJ; Karachenets S; Gyberg DJ; Puccini S; Healy CL; Wu SC; Shearer GC; O'Connell TD
bioRxiv; 2024 Apr; ():. PubMed ID: 38659901
[TBL] [Abstract][Full Text] [Related]
4. Docosahexaenoic Acid Attenuates the Progression of Nonalcoholic Steatohepatitis by Suppressing the Adipocyte Inflammation via the G Protein-Coupled Receptor 120/Free Fatty Acid Receptor 4 Pathway.
Nakamoto K; Tokuyama S
Pharmacology; 2022; 107(5-6):330-338. PubMed ID: 35189618
[TBL] [Abstract][Full Text] [Related]
5. Free fatty acid receptor 4-β-arrestin 2 pathway mediates the effects of different classes of unsaturated fatty acids in osteoclasts and osteoblasts.
Kasonga AE; Kruger MC; Coetzee M
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):281-289. PubMed ID: 30578965
[TBL] [Abstract][Full Text] [Related]
6. EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4.
Eclov JA; Qian Q; Redetzke R; Chen Q; Wu SC; Healy CL; Ortmeier SB; Harmon E; Shearer GC; O'Connell TD
J Lipid Res; 2015 Dec; 56(12):2297-308. PubMed ID: 26435012
[TBL] [Abstract][Full Text] [Related]
7. Autocrine negative feedback regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT.
Husted AS; Ekberg JH; Tripp E; Nissen TAD; Meijnikman S; O'Brien SL; Ulven T; Acherman Y; Bruin SC; Nieuwdorp M; Gerhart-Hines Z; Calebiro D; Dragsted LO; Schwartz TW
Mol Metab; 2020 Dec; 42():101103. PubMed ID: 33091626
[TBL] [Abstract][Full Text] [Related]
8. FFAR4: A New Player in Cardiometabolic Disease?
Stuttgen GM; Sahoo D
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 34043793
[TBL] [Abstract][Full Text] [Related]
9. In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice.
Shewale SV; Brown AL; Bi X; Boudyguina E; Sawyer JK; Alexander-Miller MA; Parks JS
J Lipid Res; 2017 Jan; 58(1):236-246. PubMed ID: 27811230
[TBL] [Abstract][Full Text] [Related]
10. Eicosapentaenoic Acid Potentiates Brown Thermogenesis through FFAR4-dependent Up-regulation of miR-30b and miR-378.
Kim J; Okla M; Erickson A; Carr T; Natarajan SK; Chung S
J Biol Chem; 2016 Sep; 291(39):20551-62. PubMed ID: 27489163
[TBL] [Abstract][Full Text] [Related]
11. Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling.
Nagai T; Anzai T; Mano Y; Kaneko H; Anzai A; Sugano Y; Maekawa Y; Takahashi T; Yoshikawa T; Fukuda K
Heart Vessels; 2013 May; 28(3):404-11. PubMed ID: 22875408
[TBL] [Abstract][Full Text] [Related]
12. ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.
O'Connell TD; Block RC; Huang SP; Shearer GC
J Mol Cell Cardiol; 2017 Feb; 103():74-92. PubMed ID: 27986444
[TBL] [Abstract][Full Text] [Related]
13. Endogenously generated omega-3 fatty acids attenuate vascular inflammation and neointimal hyperplasia by interaction with free fatty acid receptor 4 in mice.
Li X; Ballantyne LL; Che X; Mewburn JD; Kang JX; Barkley RM; Murphy RC; Yu Y; Funk CD
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25845931
[TBL] [Abstract][Full Text] [Related]
14. Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain.
Rey C; Delpech JC; Madore C; Nadjar A; Greenhalgh AD; Amadieu C; Aubert A; Pallet V; Vaysse C; Layé S; Joffre C
Brain Behav Immun; 2019 Feb; 76():17-27. PubMed ID: 30086401
[TBL] [Abstract][Full Text] [Related]
15. Short-term but not long-term high fat diet feeding protects against pressure overload-induced heart failure through activation of mitophagy.
Tan Y; Li M; Wu G; Lou J; Feng M; Xu J; Zhou J; Zhang P; Yang H; Dong L; Li J; Zhang X; Gao F
Life Sci; 2021 May; 272():119242. PubMed ID: 33607155
[TBL] [Abstract][Full Text] [Related]
16. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
[TBL] [Abstract][Full Text] [Related]
17. Fish oil and flax seed oil supplemented diets increase FFAR4 expression in the rat colon.
Cheshmehkani A; Senatorov IS; Kandi P; Singh M; Britt A; Hayslett R; Moniri NH
Inflamm Res; 2015 Oct; 64(10):809-815. PubMed ID: 26275932
[TBL] [Abstract][Full Text] [Related]
18. Novel identification of the free fatty acid receptor FFAR1 that promotes contraction in airway smooth muscle.
Mizuta K; Zhang Y; Mizuta F; Hoshijima H; Shiga T; Masaki E; Emala CW
Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(9):L970-82. PubMed ID: 26342087
[TBL] [Abstract][Full Text] [Related]
19. Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic Disease.
O'Connell TD; Murphy KA; Zhang N; Puccini SJ; Healy CL; Harsch BA; Zhang MJ; Shearer GC
Physiology (Bethesda); 2022 Nov; 37(6):311-322. PubMed ID: 35944007
[TBL] [Abstract][Full Text] [Related]
20. 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling.
Endo J; Sano M; Isobe Y; Fukuda K; Kang JX; Arai H; Arita M
J Exp Med; 2014 Jul; 211(8):1673-87. PubMed ID: 25049337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
